MTIP
IPCI

Magee Thomson Investment Partners’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Magee Thomson Investment Partners’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-182
Closed -$6K – 160
2014
Q2 		$6K Sell
182
-1
-0.5% -$39 ﹤0.01% 121
2014
Q1 		$8K Buy
+183
New +$7.33K ﹤0.01% 114

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Magee Thomson Investment Partners's IPCI Position: Q3 2014 in Review

Magee Thomson Investment Partners sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2014, closing a stake of 182 shares — an estimated $6K sold.

Magee Thomson Investment Partners first reported a position in IPCI in Q1 2014 and held it in 2 quarters. The position peaked at $8K in Q1 2014. 20 funds tracked by Wall St. Rank hold IPCI as of Q3 2014.

  • Magee Thomson Investment Partners reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2014 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 182 Intellipharmaceuticals International Inc. shares in Q3 2014, an estimated $6K.
  • Magee Thomson Investment Partners first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 2 quarters.
  • Magee Thomson Investment Partners's Intellipharmaceuticals International Inc. position peaked at $8K in Q1 2014.
  • 20 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2014.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2014, filed 5 Nov 2014.